Copyright
©The Author(s) 2022.
World J Gastroenterol. May 28, 2022; 28(20): 2227-2242
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2227
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2227
Table 1 Indications of small bowel capsule endoscopy (grouped by gender)
All cases | Male | Female | |
Patient characteristics | |||
n | 284 | 149 | 135 |
Age (mean ± SD) | 44.0 ± 13.3 | 44.0 ± 13.3 | 44.0 ± 13.3 |
BMI | 26.5 | 27.1 | 25.5 |
Indications | |||
OGiV | 61 (21.5%) | 30 (20.1%) | 31 (22.9%) |
Celiac disease | 80 (28.2%) | 40 (26.8%) | 40 (29.7%) |
Crohn’s or susp. Crohn’s | 47 (16.5%) | 31 (20.9%) | 16 (11.9%) |
Unexplained abdominal pain | 92 (32.4%) | 47 (31.5%) | 45 (33.3%) |
Susp. SB tumor | 4 (1.4%) | 1 (0.7%) | 3 (2.2%) |
13C urea breath test | |||
No. of performed tests | 110(38.7%) | 56 (50.1%) | 54 (49.1%) |
Positive | 36 (32.7%) | 16 (44.4%) | 20 (55.6%) |
Negative | 74 (67.3%) | 40 (54%) | 34 (46%) |
Table 2 The results of Helicobacter pylori C13 urea breath tests
n | H. pylori positive | % | H. pylori negative | % | χ2 | P value | ||
Normal | 30 | 7 | 23% | 23 | 77% | 0.9775 | 0.3228 | NS |
Minor proximalgastritis | 19 | 9 | 47% | 10 | 53% | 1.529 | 0.2163 | NS |
Minor antralgastritis | 19 | 4 | 21% | 15 | 79% | 1.0322 | 0.3096 | NS |
Active, erosive antralgastritis | 15 | 6 | 40% | 9 | 60% | 0.3129 | 0.5759 | NS |
Proximal erosivegastritis | 22 | 7 | 32% | 15 | 68% | 0.0069 | 0.9338 | NS |
Pangastritis (proximal and antral) | 4 | 3 | 75% | 1 | 25% | 0.5 | 0.4795 | NS |
Total HP tested patients | 110 | 36 | 33% | 74 | 67% | - | - | - |
Table 3 Mean gastric, small bowel, and overall transit times of magnetically controlled capsule endoscopy
Transit time | All cases | SD | Male | Female |
Stomach | 0 h 47 min 40 s | 0 h 43 min 29 s | 0 h 44 min 15 s | 0 h 51 min 14 s |
Small bowel | 3 h 46 min 22 s | 2 h 1 min 24 s | 3 h 52 min 46 s | 3 h 38 min 21 s |
Total | 5 h 48 min 35 s | 1 h 50 min 49 s | 5 h 46 min 37 s | 5 h 50 min 18 s |
Table 4 Diagnostic yield of magnetically controlled capsule endoscopy
Diagnostic yield | Major | Minor | Total |
Total | 38 (13.3%) | 195 (68.6%) | 233 (81.9%) |
Gastric | 14 (4.9%) | 159 (55.9%) | 173 (60.8%) |
SB | 24 (8.4%) | 36 (12.7%) | 60 (21.1%) |
Table 5 Distribution of pathologies detected by magnetically controlled capsule endoscopy
Polyp ventriculi | Ulcus ventriculi | Coeliakia | Crohn | Gastritis | Small intestinal diverticula | Angiodysplasia | Aspecific infalmmation in small bowel | |
Major pathologies | 5 | 9 | 1 | 23 | 159 | 1 | 26 | 9 |
Table 6 Distribution of different types of transpyloric transit in complete and incomplete small bowel studies
Cases | Mean total transit time | Mean gastric transit time | Mean SB transit time | Transpyloric transit | |||
With magnet by automatic protocol | With magnet manually | Without magnet | |||||
Total study population | 284 | 5 h 48 min 35 s | 0 h 47 min 40 s | 3 h 46 min 22 s | 56 (19.7%) | 63 (22.2%) | 165 (58.1%) |
Incomplete studies | 18 (6.3%) | 7 h 13 min 41 s | 0 h 52 min 35 s | 6 h 19 min 51 s | 2 | 5 | 11 |
The capsule depleted (> 5 h) | 10 (3.5%) | 9 h 12 min 9 s | 0 h 46 min 5 s | 8 h 26 min 4 s | 0 | 3 | 7 |
The capsule depleted (< 5 h) | 3 (1%) | 2 h 23 min 25 s | 0 h 24 min 9 s | 1 h 51 min 22 s | 1 | 0 | 2 |
The patient requested to terminate | 3 (1%) | 4 h 45 min 9 s | 0 h 50 min 3 s | 3 h 55 min 6 s | 1 | 1 | 1 |
The capsule stopped because of a disease | 2 (0.7%) | 8 h 19 min 36 s | 2 h 11 min 33 s | 6 h 8 min 33 s | 0 | 1 | 1 |
- Citation: Szalai M, Helle K, Lovász BD, Finta Á, Rosztóczy A, Oczella L, Madácsy L. First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities. World J Gastroenterol 2022; 28(20): 2227-2242
- URL: https://www.wjgnet.com/1007-9327/full/v28/i20/2227.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i20.2227